Where is the money flowing? Into regenerative medicine

Where is the money flowing? Into regenerative medicine

April 19th News Story ImageA recent report from Goldman Sachs, featured in an article on News Max Finance strongly indicates that regenerative medicine is continuing to be a an attractive option for investment.

The GS report is entitled “The Coming Age of Regenerative Medicine”, and to quote from it “venture capital in companies pursuing regenerative medicine increased from $296 million in 2011 to $807 million in 2016, growing roughly 34% year-over-year.”

The report also states that 80 regenerative-medicine companies have gained investment with the last 3 years, representING approximately 50% of the top VC deals in 2015 and 2016.

Grace Century President and Director of Research Scott Wolf said “This continues to show that our research was right 6 years ago. Regenerative medicine is the new Gold Rush.”

Read the full article on News Max Finance here